Operating profit before amortization: regencellbioscience.com (RGC)
The speculative potential of Regencell Bioscience (RGC) is based on the outcomes of drug trials for autism and ADHD. Meanwhile, low data transparency raises doubts about management's ability to monetize this research. A lack of alliances with Big Pharma leaves the company as a lone player. This EBITDA trend captures financial stability, where the value of 0.00 corresponds to the current absolute operating profit metric.
%20Operating%20profit%20EBITDA&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_RGC_-_Regencell-Bioscience_-_Operating-profit-EBITDA "Regencell Bioscience Ltd - RGC Operating profit before deduction of amortization (period 11/23/2025 - 11/10/2026) | 👁️GURU.Markets👁️")
Summary analytical data breakdowns for Regencell Bioscience Holdings Limited (RGC)
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- balance sheet net asset value indicators:
- business debt structure and liquidity details:
Debt to Equity Regencell Bioscience|RGC - Long-Term Debt to Equity|Short-Term Debt to Equity Regencell Bioscience Ltd|RGC - Company Total Debt|Debt to Net Assets Ratio Regencell Bioscience|RGC - Company Long-Term Debts|Company Short-Term Debt Regencell Bioscience|Interim Coverage Ratio regencellbioscience.com
- earnings and multiples data:
RGC - Company Net Income|Expected Net Profit Regencell Bioscience|RGC - Price to Earnings Ratio|Market Cap to Projected Earnings regencellbioscience.com|RGC - PEG Multiple|Enterprise Value to EBITDA Ratio Regencell Bioscience|RGC - Operating profit EBITDA|Net earnings per share for the last four quarters Regencell Bioscience|RGC - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months regencellbioscience.com|RGC - Earnings per share growth in current year|Projected earnings per share growth rate for next year Regencell Bioscience
Fundamental company valuation:Regencell Corp
To minimize risks during long-term investing, monitoring actual liquidity inflows is critical, as EBITDA reflects the real volume of cash generated in monetary terms without accounting for accounting lags. For Regencell Bioscience (RGC), which creates niche plant-based formulas for early-stage ADHD, this indicator serves as a measure of operational resilience and the ability to fund the development of new medical standards.
Who Regencell Bioscience competes with
Biogen Idec (BIIB) - Profit before interest, taxes and amortization|NBIX - Profit before payment of interest, taxes and amortization|AXSM (axsome.com) - Operating profit before amortization|ACAD: Operating profit EBITDA|Operating profit before deduction of amortization Xenon Pharmaceuticals Inc.|VKTX (Viking Pharma) - Operating profit EBITDA|Profit before interest, taxes and amortization Supernus Corp SUPN|Profit before payment of interest, taxes and amortization Catalyst Pharmaceuticals (CPRX)|Profit before payment of interest, taxes and amortization DNLI (denalitherapeutics.com)|Profit before payment of interest, taxes and amortization Harmony Biosciences Holdings, Inc. HRMY|Biohaven Ltd - Profit before payment of interest, taxes and amortization|AMLX: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization TRVI (Trevi Corp)|PRAX: Operating profit EBITDA|AVXL (anavex.com) - Profit before payment of interest, taxes and amortization|CBLL (CeriBell) - Operating profit EBITDA|Prothena Corporation PLC (PRTA) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Alector, Inc. (ALEC)|ANNX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Omeros OMER|Operating income before deduction of amortization neurogene.com (NGNE)|AC Immune SA - Operating profit EBITDA|Voyager Therapeutics Inc (VYGR) - Operating profit before deduction of amortization|NMRA: Operating profit EBITDA|SCLX - Operating income before deduction of amortization|TVGN (Tevogen Bio Holdings) - Operating profit EBITDA|Profit before interest, taxes and amortization Alpha Cognition Corp ACOG|Profit before payment of interest, taxes and amortization Cognition Therapeutics, Inc. (CGTX)|Inhibikase Therapeutics Inc - Operating profit before amortization|Operating profit EBITDA SAVA (Cassava)|ASRT - Operating profit before deduction of amortization|Coya - Operating profit EBITDA|Profit before interest, taxes and amortization Vistagen Therapeutics|ovidrx.com (OVID) - Profit before payment of interest, taxes and amortization|Acumen Pharmaceuticals Inc. - Income before deduction of interest, taxes and amortization|CRVO (CervoMed Inc) - Operating profit EBITDA|ATHE - Operating profit before depreciation charges|Operating profit EBITDA CLNN|Operating profit before deduction of amortization pepgen.com PEPG|Profit before payment of interest, taxes and amortization Jupiter Neurosciences JUNS|RLMD: Operating profit before amortization|Annovis Bio Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Grace Therapeutics, Inc.|AIFF (Firefly Neuroscience, Inc) - Operating profit before deduction of amortization|Klotho Neurosciences (KLTO) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization NeuroSense Therapeutics Ltd|RVPH: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization MetaVia Inc (MTVA)|NRXS - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Helius Medical Technologies HSDT|Income before deduction of interest, taxes and amortization PASG|Neuphoria - Operating profit EBITDA|Profit before interest, taxes and amortization Minerva Neurosciences Inc|ATHA: Operating profit EBITDA|Operating profit before depreciation charges Addex ADXN|ALZN (Alzamend Neuro Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Cyclerion CYCN|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|pasitheaclinics.com - Operating profit before amortization|Operating profit EBITDA CRGT (Cortigent)|ATXI - Operating profit before deduction of amortization|Brainstorm Cell - Operating profit EBITDA|Profit before interest, taxes and amortization caratherapeutics.com|Chromocell Therapeutics Corp. (CHRO) - Profit before payment of interest, taxes and amortization|ELYM (Eliem Therapeutics Inc.) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Intra-Cellular Therapies Inc.|Profit before payment of interest, taxes and amortization LBPH|Operating profit before deduction of amortization MRNS (Marinus Pharmaceuticals)|NKGN (nkgenbiotech.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NRBO (NeuroBo Pharmaceuticals, Inc.)|Sage Therapeutics Inc. - Profit before payment of interest, taxes and amortization|Neurotrope - Operating profit EBITDA|Operating income before deduction of amortization Trevena Inc TRVN|vigilneuro.com (VIGL) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization anewmeds.com (WENA)|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
